ABSTRACT Purpose: The aim of the study is to compare the expression of CD10 in invasive and non-invasive urothelial carcinomas. Methods: Primary sites of 40 cases of urothelial carcinomas were studied on H&E stained sections from the original biopsy paraffin block, out of them, 20 -with and another 20 -without smooth muscle invasion. For CD 10 expression routine immunohistochemical procedure was applied, using DAKO FLEX monoclonal mouse antihuman clon 56C6. Results: Two groups -invasive and non-invasive urothelial cancers were compared in regard to CD10 expression. The results definitely reveal that most of the cells in all invasive cancers express CD10, while in non-invasive cancers CD10 expresion was absent.
INTRODUCTION
CD10 is a cell membrane metalloprotein which participates in the postsecretory processing of neuropeptides, inactivating inflammatory and vasoactive peptides. Thus, it plays a role in the regulation of cell growth, differentiation, adhesion, invasion, and angiogenesis via enzymatic hydrolysis of various peptide hormones (1, 2, 3) . CD10 is expressed in normal and neoplastic tissues (3, 4) ; in neoplastic processes, CD10 is expressed at different stages in the course of the disease. Studies conducted on human tumors reveal that CD10 activity exerts different influences on different tumor types (5-9). Loss of CD10 expression in prostate (10, 11), lung (12), and endometrial tumors (13) accelerates tumor development and progression. And in these tumors, CD10 is thought to function as a tumor suppressor. In melanomas (14) , breast cancers (15) , and colon tumors (16) (18) (19) (20) . In addition, CD10 expressing cells are supposed to have increased potential for invasion and metastases. In this regard, literary data are incomplete and even contradictory. The aim of the study is to compare the expression of CD10 in invasive and non-invasive urothelial carcinomas.
MATERIALS AND METHODS
Primary sites of 40 cases of urothelial carcinoma were studied on H&E stained sections from the original biopsy paraffin block, out of them, 20 -with and another 20 -without smooth muscle invasion. For CD10 expression routine immunohistochemical procedure was applied, using DAKO FLEX monoclonal mouse antihuman clon 56C6.
RESULTS
We compared the expression of CD10 in two groups of invasive and non-invasive urothelial cancers. The results definitely reveal that most of the cells in all invasive cancers express CD10 (findings illustrated in Figure 1a ) and all non-invasive cancers are composed of predominantly CD10 negative cells (Figure  1b) . The normal covering epithelium (best visible in Figure 1b) is also intensively positive compared to the adjacent entirely negative cancer. In addition, some single, or grouped CD positive cells scattered in the stroma or arranged perivascularly were also present. Their eventual significance remains to be further elucidated. 
DISCUSSION
Our results demonstrate an evident link between CD10 expression and higher stage of the tumor in contrast with other reports that CD10 expresion is found to be related to the histologic grade only (21) . In addition, our findings show a correlation between the invasive properties of the tumor and CD10 expression.
On the other hand, it is suggested that CD10 is widely expressed in noninvasive urothelial carcinoma (4) Having in mind these contradictory data, we believe that our results provide convinsing evidense at least for CD10 role in urothelial cancer invasiveness in underlying smooth muscle. Even more, if occasional CD10 posirtive tumor cells are established in a noninvasive cancer, this feature may be regarded as a potential for future invasion. The exact mechanism for this potential need to be further clarified.
